Neuberger Berman Group LLC Grows Stock Holdings in Docusign Inc. $DOCU

Neuberger Berman Group LLC boosted its stake in shares of Docusign Inc. (NASDAQ:DOCU) by 17.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 51,294 shares of the company’s stock after purchasing an additional 7,511 shares during the period. Neuberger Berman Group LLC’s holdings in Docusign were worth $3,995,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Banque Transatlantique SA bought a new position in shares of Docusign during the 1st quarter valued at $26,000. Summit Securities Group LLC purchased a new stake in Docusign during the first quarter valued at $34,000. Rise Advisors LLC lifted its holdings in Docusign by 864.6% in the first quarter. Rise Advisors LLC now owns 463 shares of the company’s stock valued at $38,000 after acquiring an additional 415 shares during the period. WPG Advisers LLC bought a new position in Docusign in the first quarter valued at about $39,000. Finally, Twin Peaks Wealth Advisors LLC purchased a new position in Docusign in the second quarter worth about $43,000. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently commented on DOCU. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Docusign in a research report on Wednesday, October 8th. Morgan Stanley upped their target price on shares of Docusign from $86.00 to $90.00 and gave the company an “equal weight” rating in a report on Monday, September 8th. Wedbush decreased their price target on shares of Docusign from $85.00 to $75.00 and set a “neutral” rating on the stock in a research report on Friday, December 5th. Evercore ISI dropped their price target on shares of Docusign from $92.00 to $80.00 and set an “in-line” rating on the stock in a research note on Friday, December 5th. Finally, UBS Group reduced their price objective on Docusign from $85.00 to $75.00 and set a “neutral” rating for the company in a research note on Friday, December 5th. Four research analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $86.71.

Docusign Price Performance

Shares of NASDAQ:DOCU opened at $71.11 on Monday. The company has a market capitalization of $14.24 billion, a P/E ratio of 49.73, a P/E/G ratio of 3.57 and a beta of 0.98. Docusign Inc. has a 1-year low of $63.41 and a 1-year high of $99.71. The firm’s 50 day simple moving average is $69.18 and its two-hundred day simple moving average is $74.52.

Insider Buying and Selling

In other Docusign news, CRO Paula Hansen sold 6,000 shares of the stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $71.33, for a total value of $427,980.00. Following the completion of the sale, the executive owned 58,968 shares in the company, valued at approximately $4,206,187.44. This represents a 9.24% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Robert Chatwani sold 13,817 shares of the business’s stock in a transaction dated Wednesday, September 17th. The shares were sold at an average price of $83.10, for a total value of $1,148,192.70. Following the completion of the transaction, the insider owned 71,162 shares in the company, valued at $5,913,562.20. The trade was a 16.26% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 86,302 shares of company stock worth $6,359,253 in the last three months. Corporate insiders own 1.66% of the company’s stock.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.